Health Care & Life Sciences » Pharmaceuticals | Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.68
Market Cap
$9.72 M
Shares Outstanding
9.04 M
Public Float
4.37 M

Profile

Address
1880 Century Park East
Los Angeles California 90067
United States
Employees -
Website http://www.ritterpharmaceuticals.com
Updated 07/08/2019
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J.

Financials

View All
Created with Highcharts 5.0.14Ritter Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.2 0952 0952 4732 4738 7878 78718 38418 3847 8637 86316 86816 86820132014201520162017201805k10k15k20k

Ira E. Ritter
Executive Chairman & Chief Strategic Officer
Andrew J. Ritter
President, CEO, Secretary & Director